#NASHCongress registration is now open meet us at the London Marriott Heathrow Hotel

We're exhibiting today at #NASH Congress ! Visit us at stand 4 to find out more about the Glyco Liver Profile, our non-invasive novel glycomic-based test for hepatic monitoring. #NASH #NAFLD

Our #CEO , Dr Rajarshi Banerjee, presenting on Multiparametric #MRI and #liver disease at the Global #NASHCongress last week. Let us know if you have any questions.

Hacking metabolism in NAFLD #NASHCONGRESS

Autotaxin and NASH #NASHCONGRESS

It's lunch time at the #NASHCongress !

Grab a bite and drop by Booth #1 to chat with us about how our #DigitalPathology Image Analysis Services can address your needs in NASH/NAFLD and Fibrosis R&D.

We look forward to meeting you!

Non invasive Biomarkers for NAFLD Quentin M. Anstee #NASHCONGRESS

Our Chief Medical Officer, Stephen Williams, M.D., Ph.D., will be speaking at the Global #NASHCongress about the discovery and validation of protein signatures for NAFLD risk and NASH status. Don't miss this presentation about the promise of plasma #protein patterns.

Delighted to be attending the 2nd Global #NASH Congress organised by Life Sciences in London and be a part of the expert community to address the #NASH epidemic. #NAFLD #LiverDisease #Loveyourliver #NHSG

It's day 2 of the #NASH Congress in London. If you haven't already, stop by stand 4 to learn more about our non-invasive Glyco Liver Profile test #NASH #NAFLD bit.ly/2Dbchdz

Join us for a keynote talk on non-invasive biomarkers at the 4th Global NASH Congress
#NASHCongress #LiquidBiopsy #Bioinformatics #LiverBiopsy #Biomarkers

On the role of the #gutmicrobiota in #NASH resolution after bariatric surgery. Bruno Ramos-Molina, PhD on 🔥🔥🔥 #NASH Congress

Academic and Industry partners working together LITMUS_Project presented at #NASHCONGRESS

Enjoy your lunch and come see our Quantification of Fat Accumulation in Liver demo at our booth #NASH Congress #deeplearning #digitalpathology #NAFLD #NASH

See precision demonstration of pharmacodynamic mechanistic impacts on individual liver components with multiple longitudinal measurements. Join us at the 4th Global NASH Congress to learn more. hubs.li/H0L_Ky-0
#NASHCongress #LiquidBiopsy #LiverBiopsy

Great talk from Jonathan G. Stine, MD MSc, FACP on physical activity as a powerful tool to counteract #NAFLD , and how to make it achievable in real life #NASHCongress .

Looking forward to attending the #nashcongress in London! 2 days of all things new in #NASH .

It's the second and final day at the #NASHCongress .

If you haven't already, visit Booth #1 to learn more about our #DigitalPathology Image Analysis Services to support NASH/NAFLD and Fibrosis R&D.

You can grab one of our brochures and a free pen!

If you are attending this year's #NASHCongress in London, don’t miss Madrigal Chief Medical Officer Becky Taub’s presentation on NASH drug development tomorrow at 14:10 BST. #LiverTwitter

Up next for #NASH Congress is the one and only sidbarritt4 to talk about emerging evidence for NITs in #NASH